Insider · CIK 0001631338

THEUER CHARLES

Reports to the SEC for 3 companies · EMERYVILLE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001631338

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-17	FDMT4D Molecular Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2025-12-12	FDMT4D Molecular Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,333 sh	$1.14	+$10.6K	41,684
2025-12-12	FDMT4D Molecular Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,333 sh	—	—	0
2025-06-17	FDMT4D Molecular Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2024-06-20	Oncternal Therapeutics, Inc.Stock OptionsA Award	Director	AAward	+2,200 sh	—	—	2,200
2024-05-21	FDMT4D Molecular Therapeutics, Inc. · Stock Option (Right To Buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2024-03-12	Tracon Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+518K sh	—	—	518,300
2023-10-20	Tracon Pharmaceuticals, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+3,500 sh	$0.13	+$466.55	406,417
2023-06-28	Oncternal Therapeutics, Inc.Stock OptionsA Award	Director	AAward	+25K sh	—	—	25,000
2023-05-23	FDMT4D Molecular Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2023-04-27	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+47K sh	$0.75	+$35.3K	399,417
2023-04-26	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+3,999 sh	$0.66	+$2,639.34	352,417
2023-04-20	Tracon Pharmaceuticals, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+3,500 sh	$0.14	+$481.95	402,917
2023-03-01	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+4,800 sh	$1.52	+$7,296	344,918
2023-02-28	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+200 sh	$1.52	+$304	340,118
2023-02-01	Tracon Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+332K sh	—	—	332,000
2023-01-18	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+6,800 sh	$1.62	+$11K	339,918
2022-12-14	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+23K sh	$1.29	+$29.8K	333,118
2022-11-18	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+13.9K sh	$1.41	+$19.6K	310,118
2022-11-03	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+9,200 sh	$1.52	+$14K	296,218
2022-11-02	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+6,000 sh	$1.59	+$9,540	287,018
2022-10-07	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+5,000 sh	$1.77	+$8,850	277,518
2022-10-03	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+5,000 sh	$1.67	+$8,350	272,518
2022-09-22	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+5,000 sh	$1.76	+$8,800	267,518
2022-07-22	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+4,500 sh	$1.85	+$8,325	262,518
2022-07-13	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+3,000 sh	$1.84	+$5,520	258,018
2022-07-12	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+3,000 sh	$1.87	+$5,610	255,018
2022-06-16	Oncternal Therapeutics, Inc.Stock OptionsA Award	Director	AAward	+25K sh	—	—	25,000
2022-05-23	FDMT4D Molecular Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2022-05-09	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+10K sh	$1.85	+$18.5K	252,018
2022-05-06	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+2,500 sh	$1.97	+$4,925	242,018
2022-04-29	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+5,000 sh	$1.97	+$9,854.5	239,518
2022-04-21	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+4,500 sh	$2.30	+$10.4K	234,518
2022-04-08	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+2,000 sh	$2.50	+$5,000	226,518
2022-03-30	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+4,000 sh	$2.70	+$10.8K	224,518
2022-03-21	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+1,200 sh	$2.45	+$2,940	220,518
2022-01-28	Tracon Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+265K sh	—	—	265,000
2021-11-19	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+3,500 sh	$2.82	+$9,870	219,318
2021-11-18	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+681 sh	$2.88	+$1,961.28	215,818
2021-11-05	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+1,000 sh	$3.41	+$3,410	212,137
2021-11-05	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+3,000 sh	$3.42	+$10.2K	215,137
2021-08-16	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+3,000 sh	$3.56	+$10.7K	207,732
2021-05-25	Oncternal Therapeutics, Inc.Stock OptionsA Award	Director	AAward	+25K sh	—	—	25,000
2021-05-17	FDMT4D Molecular Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2021-01-29	Tracon Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+180K sh	—	—	180,000
2021-01-27	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+11K sh	$8.98	+$98.8K	201,232
2020-12-29	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+1,000 sh	$9.98	+$9,980	190,232
2020-10-21	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+2,000 sh	$4.38	+$8,769	189,232
2020-09-23	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+4,893 sh	$4.72	+$23.1K	186,775
2020-09-23	Tracon Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+107 sh	$4.72	+$505.051	186,882

Recent filings

Accepted (ET)
Jun 184
THEUER CHARLES0001193125-26-276166
SEC(opens sec.gov)
Dec 164
THEUER CHARLES0001193125-25-320992
SEC(opens sec.gov)
Jun 204
THEUER CHARLES0000950170-25-088487
SEC(opens sec.gov)
Jun 244
THEUER CHARLES0000950170-24-076705
SEC(opens sec.gov)
May 234
THEUER CHARLES0000950170-24-064220
SEC(opens sec.gov)
Mar 134
THEUER CHARLES0001415889-24-007846
SEC(opens sec.gov)
Jun 304
THEUER CHARLES0001209191-23-040285
SEC(opens sec.gov)
May 254
THEUER CHARLES0001610717-23-000070
SEC(opens sec.gov)
Apr 284
THEUER CHARLES0001209191-23-025930
SEC(opens sec.gov)
Mar 24
THEUER CHARLES0001209191-23-014434
SEC(opens sec.gov)
Feb 34
THEUER CHARLES0001209191-23-007191
SEC(opens sec.gov)
Jan 194
THEUER CHARLES0001209191-23-003934
SEC(opens sec.gov)
Dec 154
THEUER CHARLES0001209191-22-061329
SEC(opens sec.gov)
Nov 224
THEUER CHARLES0001209191-22-058302
SEC(opens sec.gov)
Nov 44
THEUER CHARLES0001209191-22-055687
SEC(opens sec.gov)

Companies

Address

C/O 4D MOLECULAR THERAPEUTICS, INC. 5858 HORTON STREET #455

EMERYVILLE, CA, 94608